LZOEX Performance — Lazard Emerging Markets Equity Portfolio, Open Shares
Data updated: 2026-08-21
LZOEX returned +22.24% year to date and +43.40% over one year to Jun 2026. Annualised returns are +25.90% over 3 years and +12.75% over 5 years. The fund beat its Emerging Markets Equity category average: $100 invested three years ago grew to $200, against $179 for the category, and to $143 over one year, against $141. Volatility over the past three years was 13.84% a year. In the 12 months to Jun 2026 the fund took in a net $2.8B, and assets reached $9.24B.
LZOEX Growth of $100
What $100 invested in Lazard Emerging Markets Equity Portfolio grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Equity category average over the same months.
| Period | LZOEX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $143 | $141 |
| 3 years (Jul 2023 – Jun 2026) | $200 | $179 |
| 5 years (Jul 2021 – Jun 2026) | $182 | $144 |
| Since data start (Jul 2019 – Jun 2026) | $215 | $195 |
LZOEX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +22.24% |
| 1 year | +43.40% |
| 3 years (annualised) | +25.90% |
| 5 years (annualised) | +12.75% |
LZOEX Annual Returns
Calendar-year total returns of Lazard Emerging Markets Equity Portfolio, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +22.24% |
| 2025 | +41.02% |
| 2024 | +7.33% |
| 2023 | +22.03% |
| 2022 | −15.08% |
| 2021 | +5.14% |
| 2020 | −0.28% |
| 2019 (Jul–Dec) | +6.73% |
LZOEX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +9.4% | +5.9% | −8.1% | +9.4% | +6.6% | −1.7% | — | — | — | — | — | — |
| 2025 | +4.4% | 0.0% | +1.7% | +2.5% | +4.1% | +6.1% | +0.6% | +2.4% | +3.6% | +5.6% | +1.2% | +2.9% |
| 2024 | −3.4% | +4.4% | +1.6% | +0.6% | +2.4% | +2.5% | +0.8% | +2.6% | +5.7% | −5.9% | −2.3% | −1.3% |
| 2023 | +8.9% | −3.6% | +2.7% | +0.9% | −2.2% | +6.4% | +4.1% | −4.3% | −0.9% | −2.0% | +7.1% | +4.2% |
| 2022 | +2.0% | −4.4% | −1.7% | −5.1% | +3.3% | −9.7% | +1.1% | −1.4% | −10.6% | +1.2% | +14.1% | −2.7% |
| 2021 | +0.3% | +1.9% | +2.7% | +1.0% | +5.0% | −0.6% | −4.2% | +2.6% | −2.9% | +0.2% | −4.4% | +4.0% |
| 2020 | −6.2% | −6.8% | −20.1% | +7.1% | +1.9% | +3.0% | +5.3% | −1.1% | −1.6% | 0.0% | +14.2% | +8.6% |
| 2019 | — | — | — | — | — | — | −2.1% | −5.3% | +3.6% | +3.7% | −0.1% | +7.1% |
LZOEX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 13.84%
- 3-year Sharpe ratio: 1.55 (vs 4.5% risk-free rate)
- Best month: +9.45% (Apr 2026)
- Worst month: −8.05% (Mar 2026)
LZOEX Fund Flows
Monthly money in and out of Lazard Emerging Markets Equity Portfolio, from SEC Form N-PORT.
- 12-month net flow: $2.8B
- 12-month gross sales (incl. reinvestments): $4.3B
- Sales ÷ redemptions: 2.80×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $190.9M | $279.1M | −$88.1M |
| May 2026 | $243.2M | $134.9M | $108.3M |
| Apr 2026 | $284.1M | $140.1M | $144.0M |
| Mar 2026 | $298.4M | $175.4M | $123.0M |
| Feb 2026 | $525.7M | $124.0M | $401.7M |
| Jan 2026 | $472.5M | $99.3M | $373.3M |
| Dec 2025 | $313.3M | $108.5M | $204.8M |
| Nov 2025 | $377.3M | $60.6M | $316.7M |
| Oct 2025 | $161.8M | $98.0M | $63.9M |
| Sep 2025 | $180.2M | $207.5M | −$27.3M |
| Aug 2025 | $408.2M | $46.3M | $362.0M |
| Jul 2025 | $843.3M | $59.1M | $784.1M |
LZOEX Assets Under Management
Net assets of Lazard Emerging Markets Equity Portfolio by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $9.24B |
| 2026-03-31 | $7.89B |
| 2025-12-31 | $6.58B |
| 2025-09-30 | $5.55B |
| 2025-06-30 | $4.10B |
| 2025-03-31 | $3.42B |
| 2024-12-31 | $3.24B |
| 2024-09-30 | $3.11B |
| 2024-06-30 | $2.87B |
| 2024-03-31 | $2.70B |
| 2023-12-31 | $2.69B |
| 2023-09-30 | $2.52B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.